Alliancebernstein L.P. Vir Biotechnology, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 109,620 shares of VIR stock, worth $780,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,620

Previous 109,620 -0.0%

Holding current value

$780,494

Previous $975,000 15.79%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$8.6 - $11.9 $23 Million - $31.8 Million	-2,671,429 Reduced 96.06%	109,620 $1.11 Million
Q4 2023 Feb 14, 2024	SELL	$7.76 - $10.29 $905,475 - $1.2 Million	-116,685 Reduced 4.03%	2,781,049 $28 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $24.62 $1.33 Million - $3.59 Million	146,018 Added 5.31%	2,897,734 $27.2 Million
Q2 2023 Aug 15, 2023	BUY	$23.2 - $27.29 $66,607 - $78,349	2,871 Added 0.1%	2,751,716 $67.5 Million
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $8.79 Million - $12.2 Million	394,986 Added 16.78%	2,748,845 $64 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $390,038 - $551,447	19,541 Added 0.84%	2,353,859 $59.6 Million
Q3 2022 Nov 15, 2022	SELL	$18.26 - $31.1 $8.51 Million - $14.5 Million	-466,219 Reduced 16.65%	2,334,318 $45 Million
Q2 2022 Aug 15, 2022	SELL	$19.08 - $26.7 $5.54 Million - $7.76 Million	-290,568 Reduced 9.4%	2,800,537 $71.3 Million
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $9.97 Million - $18.8 Million	470,352 Added 17.95%	3,091,105 $79.5 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $15 Million - $26.1 Million	483,261 Added 22.61%	2,620,753 $110 Million
Q3 2021 Nov 10, 2021	BUY	$34.9 - $54.54 $574,663 - $898,055	16,466 Added 0.78%	2,137,492 $93 Million
Q2 2021 Jul 30, 2021	BUY	$38.75 - $51.0 $12.5 Million - $16.4 Million	322,247 Added 17.91%	2,121,026 $100 Million
Q1 2021 May 06, 2021	SELL	$26.34 - $83.07 $30.8 Million - $97 Million	-1,168,027 Reduced 39.37%	1,798,779 $92.2 Million
Q4 2020 Feb 08, 2021	BUY	$25.51 - $43.38 $22.6 Million - $38.4 Million	885,381 Added 42.54%	2,966,806 $79.5 Million
Q3 2020 Nov 12, 2020	BUY	$28.28 - $53.6 $4.03 Million - $7.64 Million	142,553 Added 7.35%	2,081,425 $71.5 Million
Q2 2020 Aug 13, 2020	BUY	$27.89 - $47.86 $53.5 Million - $91.8 Million	1,917,072 Added 8793.91%	1,938,872 $79.4 Million
Q1 2020 May 14, 2020	BUY	$12.04 - $60.2 $262,472 - $1.31 Million	21,800 New	21,800 $747,000

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Vir Biotechnology, Inc. Transaction History